HARVARD BIOSCIENCE, INC. Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax
HARVARD BIOSCIENCE, INC. (HBIO) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2026-06-30 was $0.00.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2026-03-31 was $0.00.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2025-06-30 was $0.00.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2025-03-31 was $0.00.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for fiscal 2025 was $0.00.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for fiscal 2024 was $0.00.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for fiscal 2023 was $0.00.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for fiscal 2022 was $0.00.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | ||
| 2025-12-31 | $0.00 10-K · filed 2026-03-13 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-13 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | ||
| 2023-12-31 | $0.00 10-K · filed 2025-03-14 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | ||
| 2022-12-31 | $0.00 10-K · filed 2024-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |